EVOQ Remedies Ltd (543500) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543500 | NSE: | Trading | Small Cap

EVOQ Remedies Share Price

3.10 0.10 3.33%
as on 05-Dec'25 11:25

EVOQ Remedies Ltd (543500) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543500 | NSE: | Trading | Small Cap

DeciZen - make an informed investing decision on EVOQ Remedies

Based on:

M-Cap below 100cr DeciZen not available

EVOQ Remedies stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
84.89
Market Cap:
7.5 Cr.
52-wk low:
2.1
52-wk high:
9.3

Is EVOQ Remedies Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of EVOQ Remedies: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
EVOQ Remedies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 68.9%2.7%246.9%9.1%7%1.9%0.4%-
Value Creation
Index
3.9-0.816.6-0.4-0.5-0.9-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3.39.11016.820.44.111.812
Sales YoY Gr.-179.1%10.5%67.5%21.5%-80.1%190.4%-
Adj EPS 0.2010.10.81.20.300
YoY Gr.--100%NA-92.1%48.8%-72.3%-87.9%-
BVPS (₹) 0010.51718.218.617.917.9
Adj Net
Profit
000.71.11.60.50.10
Cash Flow from Ops. 0-00-26.4-4.45.3-14.6-
Debt/CF from Ops. 0.2-0.30-0.3-2.20.80-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA5.3%-11.2%190.4%
Adj EPS NANA-63.2%-87.9%
BVPSNANA1.7%-3.6%
Share Price - - -41.3% -60.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
49.81.3186.99.16.81.80.30.2
Op. Profit
Mgn %
0.509.58.7-18.3-40.4-19NAN
Net Profit
Mgn %
0.307.16.57.911.20.80.9
Debt to
Equity
0.10.300.40.40.20-
Working Cap
Days
01562494165823,2181,3400
Cash Conv.
Cycle
0-34-382684021,0081480

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - EVOQ Remedies Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 11.8 -
BVPS (₹.) 17.9 -
Reserves (₹ Cr.) 20 -
P/BV 0.17 -
PE 84.89 -
From the Market
52 Week Low / High (₹) 2.11 / 9.28
All Time Low / High (₹) 2.11 / 25.00
Market Cap (₹ Cr.) 7.5
Equity (₹ Cr.) 24.9
Face Value (₹) 10
Industry PE 36.9

Management X-Ray of EVOQ Remedies:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of EVOQ Remedies - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of EVOQ Remedies

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3.259.0710.0216.7820.394.0511.76
Operating Expenses 3.239.079.0715.3224.125.6913.99
Manufacturing Costs000.060.040.090.010
Material Costs3.239.057.8513.7719.331.5613.08
Employee Cost 00.010.010.180.200.080.07
Other Costs 0.010.011.151.334.504.040.84
Operating Profit 0.0200.951.46-3.73-1.64-2.24
Operating Profit Margin (%) 0.5%0.0%9.5%8.7%-18.3%-40.4%-19.0%
Other Income 00006.022.262.41
Interest 0000000
Depreciation 000000.010.05
Exceptional Items 0000000
Profit Before Tax 0.0200.951.462.280.610.13
Tax 000.240.370.670.160.04
Profit After Tax 0.0100.721.091.620.450.09
PAT Margin (%) 0.3%0.0%7.1%6.5%7.9%11.2%0.8%
Adjusted EPS (₹)0.20.010.10.81.20.30.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.020.020.7423.1724.7925.2444.54
Share Capital 0.010.010.0113.6013.6013.6024.90
Reserves 0.010.010.739.5711.1911.6419.64
Minority Interest0000000
Debt00.0108.169.584.240
Long Term Debt00.0100000
Short Term Debt0008.169.584.240
Trade Payables2.125.626.781.21-0.543.283.50
Others Liabilities 0.0100.520.801.074.101.98
Total Liabilities 2.155.658.0533.3334.9036.8650.01

Fixed Assets

Gross Block00000.010.010.22
Accumulated Depreciation0000000
Net Fixed Assets 00000.010.010.22
CWIP 0000000
Investments 0000000
Inventories0.030.060.150.782.033.132.22
Trade Receivables1.234.726.8425.4017.221.748.62
Cash Equivalents 0.0200.033.090.150.120.21
Others Assets 0.870.871.034.0615.4931.8638.74
Total Assets 2.155.658.0533.3334.9036.8650.01

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.01-0.020.03-26.43-4.355.32-14.62
PBT 0.0200.721.462.280.610.13
Adjustment 00000.010.010.05
Changes in Working Capital -0-0.02-0.68-27.52-5.974.86-14.76
Tax Paid -0-00-0.37-0.67-0.16-0.04
Cash Flow From Investing Activity 0000-0.01-0.01-0.26
Capex 0000-0.01-0.01-0.26
Net Investments 0000000
Others 0000000
Cash Flow From Financing Activity 00029.491.42-5.3414.97
Net Proceeds from Shares 00021.330019.21
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 0008.161.42-5.34-4.24
Net Cash Flow 0.01-0.020.033.06-2.94-0.030.09

Finance Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)49.781.34186.899.136.751.810.25
ROCE (%)68.942.69246.99.126.961.920.35
Asset Turnover Ratio1.512.331.460.810.60.110.27
PAT to CFO Conversion(x)1N/A0.04-24.25-2.6911.82-162.44
Working Capital Days
Receivable Days138120210351381854161
Inventory Days324102523283
Payable Days240156288106632295

EVOQ Remedies Ltd Stock News

EVOQ Remedies Ltd FAQs

The current trading price of EVOQ Remedies on 05-Dec-2025 11:25 is ₹3.10.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of EVOQ Remedies stood at ₹7.47.
The latest P/E ratio of EVOQ Remedies as of 04-Dec-2025 is 84.89.
The latest P/B ratio of EVOQ Remedies as of 04-Dec-2025 is 0.17.
The 52-week high of EVOQ Remedies is ₹9.28 and the 52-week low is ₹2.11.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EVOQ Remedies is ₹11.76 ( Cr.) .

About EVOQ Remedies Ltd

EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise.

In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products.

EVOQ majorly does trading in following segments of pharmaceuticals raw materials:

  • Excipients
  • Nutraceuticals
  • Pellets
  • Solvents
  • Sweetners
  • Vitamins
  • Amino Acids
  • Bulk Drugs
  • Dairy Products
  • Active Pharmaceuticals Ingredients

Business area of the company

The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices.

Major events:

  • 2010: Incorporation of Company as ‘Salus Life Science and Research Private Limited’ at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956.
  • 2021: Conversion of the Company into public limited company, the name of the company was changed to ‘Evoq Remedies Limited’ and fresh Certificate of Incorporation dated July 28, 2021 was issued by Registrar of Companies, Ahmedabad.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×